ANTIPHOSPHOLIPID ANTIBODY - ANVISA Registration 10230730159
Access comprehensive regulatory information for ANTIPHOSPHOLIPID ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10230730159 and manufactured by CORGENIX, INC. The registration is held by NL COMÉRCIO EXTERIOR LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, INOVA DIAGNOSTICS, INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
10230730159
25351413965202223
52541273000147
Company Information
Dates and Status
Apr 20, 2022
VIGENTE
09/18/2025 19:00:01
ANTICORPO ANTIFOSFOLIPÍDEOS
Família MAGLUMI® IgG anti-ß2-Glicoproteína 1 (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
81504790437
Sep 16, 2024
ANTICORPO ANTIFOSFOLIPÍDEOS
Família MAGLUMI® IgM anti-ß2-Glicoproteína 1 (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
81504790438
Sep 16, 2024
ANTICORPO ANTIFOSFOLIPÍDEOS
Família iFlash-B2-Glycoprotein I IgA
SHENZHEN YHLO BIOTECH CO., LTD
80867150151
Jul 10, 2023
ANTICORPO ANTIFOSFOLIPÍDEOS
Familia iFlash-B2-Glycoprotein I IgM
SHENZHEN YHLO BIOTECH CO., LTD
80867150153
Jul 10, 2023
ANTICORPO ANTIFOSFOLIPÍDEOS
Familia iFlash-B2-Glycoprotein I IgG
SHENZHEN YHLO BIOTECH CO., LTD
80867150154
Jul 10, 2023

